Bristol-Myers Squibb | BMY - 净收入





净收入 更改 日
AbbVie USD 695M 1.12B 2026-03
Abbott USD 928M 149M 2026-06
ALKERMES USD 501K 66.98M 2026-06
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 2.51B 573M 2026-06
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Drreddys Laboratories INR 2.21B 9.89B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
J&J USD 5.53B 299M 2026-06
Medtronic USD 1.24B 100M 2026-03
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.26B 108M 2026-06
Novo Nordisk DKK 26.89B 388M 2025-12
Perrigo USD -398.6M 1.02B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 1.61B 2.42B 2026-03
Sanofi EUR 1.61B 2.42B 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03
Zoetis USD 601M 2M 2026-03